Asia Pacific Stroke Management Market

Asia Pacific Stroke Management Market By Type (Diagnostics - Computed Tomography Scan, Magnetic Resonance Imaging, Echocardiography, Carotid Ultrasound, Cerebral Angiography, Electrocardiography; Therapeutics - Tissue Plasminogen Activator, Anticoagulant, Antiplatelet), Application (Ischemic, Haemorrhagic)

Report Id: KBV-680 Publication Date: December-2017 Number of Pages: 90
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Analysis of Market Size & Trends

The Asia Pacific Stroke Management Market would witness market growth of 8.2% CAGR during the forecast period (2018 – 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth. Asia-Pacific is the region with tremendous market potential, due to rising prevalence of strokes, which is due to growing incidence of chronic diseases and use of tobacco.

Click Here For Free Insights:

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.

Scope of the Study

Market Segmentation:

By Type

  • Diagnostics
  • Computed Tomography Scan (CT Scan)
  • Magnetic Resonance Imaging (MRI)
  • Echocardiography
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Others
  • Therapeutics
  • Tissue Plasminogen Activator
  • Anticoagulant
  • Antiplatelet
  • Other Therapeutics Type

By Application                                                  

  • Ischemic Stroke
  • Hemorrhagic Stroke

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • ABBOTT Laboratories
  • B. Braun Melsungen Ag
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Medtronic Plc
  • Siemens Aktiengesellschaft
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

Related Report

Record Not Found !
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo